ライフサイエンスコーパス: lymphoscintigraphy

1 13 lymph node groups were visualized on lymphoscintigraphy.

2 assist health care practitioners considering lymphoscintigraphy.

3 rall SLN detection in comparison with planar lymphoscintigraphy.

4 th higher trial center volume or with pre-US lymphoscintigraphy.

5 mities), while they were not detectable with lymphoscintigraphy.

6 ugh imaging, including indirect radionuclide lymphoscintigraphy.

7 lymphatic US compared favorably with that at lymphoscintigraphy.

8 within the SLN, which was not possible with lymphoscintigraphy.

9 is properly diagnosed and characterized with lymphoscintigraphy.

10 biopsy type; and interval between biopsy and lymphoscintigraphy.

11 issection to be performed on the same day as lymphoscintigraphy.

12 albumin (HSA) with SLN biopsy after SC-based lymphoscintigraphy.

13 of the terms cervical cancer, SPECT/CT, and lymphoscintigraphy.

14 lling in a 23-yr-old man was investigated by lymphoscintigraphy.

15 ine (73%) of the 136 SLNs were visualized at lymphoscintigraphy; 30 (81%) of the 37 nonvisualized SLN

16 were seen in studies that used preoperative lymphoscintigraphy and dual mapping during surgery.

17 tinuity and function were demonstrable using lymphoscintigraphy and fluorescence microlymphangiograph

18 All underwent preoperative lymphoscintigraphy and intraoperative lymphatic mapping

19 Preoperative lymphoscintigraphy and intraoperative lymphatic mapping

20 into 4 groups: 1993-2005, with preoperative lymphoscintigraphy and intraoperative use of both a y-ra

21 ng intradermal hybrid tracer administration, lymphoscintigraphy and single photon emission computed t

22 ics is further hindered by the resolution of lymphoscintigraphy and SPECT.

23 nventional imaging techniques such as planar lymphoscintigraphy and SPECT/CT, preoperative sentinel n

24 cation of the SNs identified on preoperative lymphoscintigraphy and SPECT/CT.

25 SN mapping was performed using lymphoscintigraphy and SPECT/CT.

26 went SLN dissection directed by preoperative lymphoscintigraphy and vital blue dye mapping; in the re

27 ing magnetic resonance, computed tomography, lymphoscintigraphy, and emerging optical techniques with

28 of lymphatic function demonstrated by serial lymphoscintigraphy, and finally, attenuation of the fibr

29 8, 20 patients underwent Tc99 sulfur colloid lymphoscintigraphy, and SLNB was performed with use of a

30 who had breast cancer underwent preoperative lymphoscintigraphy before SLN biopsy.

31 With lymphoscintigraphy, better visualization of inguinal lym

32 dies including optical coherence tomography, lymphoscintigraphy, brain magnetic resonance and nuclear

33 ll three agents are acceptable for cutaneous lymphoscintigraphy, but reliable identification of senti

34 This study provides proof of principle for lymphoscintigraphy by receptor-mediated delivery of a no

35 Preoperative lymphoscintigraphy can identify all regional nodal basin

36 Beyond lymphoscintigraphy, clinically-relevant imaging modaliti

37 Weak lymphatic drainage at lymphoscintigraphy correlated with lymphangiectasia at M

38 Postoperative lymphoscintigraphy demonstrated at least some improvemen

39 Lymphatic US depicted 28 SLNs, while lymphoscintigraphy depicted 27 "hot spots" suspected of

40 iologic principles of lymphatic imaging with lymphoscintigraphy, discuss different qualitative and qu

41 Preoperative lymphoscintigraphy does not improve the ability to ident

42 implemented in a clinical pilot study using lymphoscintigraphy examinations as a prospective use cas

43 The AI system processed 1748 lymphoscintigraphy examinations.

44 ere correlated with corresponding results of lymphoscintigraphy examinations.

45 ion of inguinal lymph nodes was clearer with lymphoscintigraphy (five of 60 extremities).

46 There has been a resurgence in the use of lymphoscintigraphy for the external detection of lymph n

47 ern of tumor lymphatic drainage and the SLN, lymphoscintigraphy has been performed using primarily 99

48 Lymphoscintigraphy has many advantages over contrast lym

49 in breast cancer patients using preoperative lymphoscintigraphy have been reported.

50 ymphatic basins and nodes were identified by lymphoscintigraphy in all patients.

51 developed appropriate use criteria (AUC) for lymphoscintigraphy in sentinel lymph node mapping and ly

52 Data from preoperative lymphoscintigraphy, intraoperative lymphatic mapping, op

53 tic biopsy type; interval between biopsy and lymphoscintigraphy; intraoperative identification method

54 Lymphoscintigraphy is a useful technique for the evaluat

55 Lymphoscintigraphy is an important part of the mapping a

56 Although lymphoscintigraphy is commonly used for the preoperative

57 Lymphoscintigraphy is highly reproducible in the detecti

58 etary radiolabeled nanocolloid indicated for lymphoscintigraphy is not available, prostate lymph node

59 Routine preoperative lymphoscintigraphy is not necessary for the identificati

60 Lymphoscintigraphy is reproducible in detection of the s

61 Preoperative injection of Tc99 and lymphoscintigraphy is standardly performed before sentin

62 An important use of lymphoscintigraphy is to evaluate extremity edema.

63 ese models over time, both systemically with lymphoscintigraphy (LS) and locally using fluorescence m

64 All had preoperative lymphoscintigraphy (LSG) and SLN biopsy using both blue

65 parative analysis of detected lymph nodes on lymphoscintigraphy (LSG) and SLNB was performed by quant

66 t work was to clarify whether a preoperative lymphoscintigraphy (LSG) enhances staging accuracy of se

67 retrospective study was to determine whether lymphoscintigraphy (LSG) for sentinel lymph node (SNL) m

68 benefit of IMN irradiation become available, lymphoscintigraphy may be used to help guide decisions r

69 PET/CT lymphoscintigraphy may improve the detection and localiz

70 Notably, this approach parallels the current lymphoscintigraphy method but enables the direct PET vis

71 Methods: Current lymphoscintigraphy methods identify only the anatomic lo

72 ral indocyanine green (ICG) lymphography and lymphoscintigraphy of the upper extremities.

73 We aimed to compare SPECT/CT and lymphoscintigraphy on overall and bilateral sentinel lym

74 acement of 125I seeds did not interfere with lymphoscintigraphy or intraoperative identification of S

75 31) for lymphatic US and 81% (25 of 31) for lymphoscintigraphy (P =.29).

76 tudy was to determine the reproducibility of lymphoscintigraphy performed by different team members f

77 the additional value of SPECT/CT over planar lymphoscintigraphy (PI) in sentinel node (SN) detection

78 SPECT/CT (range, 62.7%-79.3%) and 66.7% for lymphoscintigraphy (range, 56.9%-75.8%), yielding a pool

79 SPECT/CT (range, 92.2%-100.0%) and 85.3% for lymphoscintigraphy (range, 70.0%-100.0%).

80 Preoperative lymphoscintigraphy revealed at least one sentinel node i

81 Imaging findings of MR lymphangiography and lymphoscintigraphy show a clear concordance.

82 Lower limb lymphoscintigraphy showed features of an unusual lymphat

83 Lymphoscintigraphy showed higher SLN detection in patien

84 Lymphoscintigraphy showed higher SLN detection in patien

85 Functional nodal drainage as demonstrated by lymphoscintigraphy shows less symmetry than anatomic stu

86 Recently, lymphoscintigraphy studies have renewed interest in IMN

87 All underwent 2 separate lymphoscintigraphy studies, which followed the same acqu

88 percent of patients showed 1-3 SLNs in both lymphoscintigraphy studies.

89 tate has proved to be an excellent agent for lymphoscintigraphy studies.

90 68 patients (96%), the findings of the first lymphoscintigraphy study were similar to those of the se

91 Lymphatic congestion lymphoscintigraphy thus provided a quantitative measure

92 Effective use of lymphoscintigraphy to plan therapy requires an understan

93 ssess reproducibility, 13 patients underwent lymphoscintigraphy twice within 2-17 days.

94 Four patients underwent lymphoscintigraphy twice, once with SC and once with HSA

95 In 11 of the 13 who underwent lymphoscintigraphy twice, sentinel node identification w

96 PET/CT study on SN detection indicated that lymphoscintigraphy using (89)Zr-nanocolloidal albumin is

97 is study, the clinical feasibility of PET/CT lymphoscintigraphy using (89)Zr-nanocolloidal albumin wa

98 developed a practice procedure for prostate lymphoscintigraphy using SPECT/CT and filtered (99m)Tc-s

99 Results: Lymphoscintigraphy was able to depict at least 1 SLN in

100 Lymphoscintigraphy was also performed.

101 Lymphoscintigraphy was followed by injection of a blue d

102 Lymphoscintigraphy was performed after intradermal injec

103 PET/CT lymphoscintigraphy was performed after peritumoral injec

104 Preoperative lymphoscintigraphy was performed at the discretion of th

105 Preoperative breast lymphoscintigraphy was performed in consecutive breast c

106 Radionuclide lymphoscintigraphy was performed to quantitate lymphatic

107 After injection at the lesion site, lymphoscintigraphy was performed with a 10-min dynamic s

108 sion computed tomography/computed tomography lymphoscintigraphy, we quantified the lymphatic flow ind

109 Five of six nodes not seen with lymphoscintigraphy were detected with lymphatic US.

110 Lymphoscintigraphy with 99mTc was performed before surge

111 re assigned to one of three groups of 17 for lymphoscintigraphy with one of three radiopharmaceutical

112 n of the sentinel lymph node is preoperative lymphoscintigraphy with technetium Tc 99m.